Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population

Current Medical Research and Opinion

Volumn 26, Issue 3, 2010, Pages 713-719

  Athyros, Vasilios G ^a   Ganotakis, Emmanuel S ^b   Tziomalos, Konstantinos ^a   Papageorgiou, Athanasios A ^a   Anagnostis, Panagiotis ^c   Griva, Theodora ^a   Kargiotis, Konstantinos ^a   Mitsiou, Eydoxia K ^a   Karagiannis, Asterios ^a   Mikhailidis, Dimitri P ^d  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c Aristotle University of Thessaloniki   (Greece)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

American Heart Association National Heart Lung and Blood Institute; Cardiovascular disease; Consensus definition; International Diabetes Federation; Metabolic syndrome; National Cholesterol Educational Program

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONSENSUS DEVELOPMENT; FEMALE; GLUCOSE BLOOD LEVEL; GREECE; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; OBESITY; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; SYNDROME DELINEATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; GREECE; HUMANS; MALE; MEDITERRANEAN REGION; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE;

EID: 76949084668     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007991003590597     Document Type: Article

References (30)

1. Alberti KG, Eckel RH, Grundy SM, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the Metabolic Syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-1645
2. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24:683-689
3. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288:2709-2716
4. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004; 173:309-314
5. Alexander CM, Landsman PB, Teutsch SM, et al.; Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003: 52:1210-1214
6. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497
7. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366:1059-1062 (Pubitemid 41338752)
8. Grundy SM, Cleeman JI, Daniels SR, et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112: 2735-2752
9. Athyros VG, Mikhailidis DP, Papageorgiou AA, et al.; METS-GREECE Collaborative Group. Prevalence of atherosclerotic cardiovascular disease among subjects with the metabolic syndrome with or without diabetes melli-tus. Curr Med Res Opin 2004;20:1691-1701
10. Athyros VG, Bouloukos VI, Pehlivanidis AN, et al.; MetS-Greece Collaborative Group. The prevalence of the METabolic Syndrome in GREECE-The MetS-GREECE Multicenter Study. Diabetes Obes Metab 2005;7:397-405
11. Athyros VG, Ganotakis ES, Elisaf MS; GREECE-METS Collaborative Group. Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol 2007;117:204-210
12. Athyros VG, Ganotakis ES, Bathianaki M, et al.; MetS-Greece Collaborative Group. Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study. Hellenic J Cardiol 2005;46:380-386
13. Milionis HJ, Kostapanos MS, Liberopoulos EN, et al. Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects. Int J Clin Pract 2007;61:545-551
14. Nilsson PM, Engström G, Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects-a population-based study comparing three different definitions. Diabet Med 2007;24:464-472
15. Moebus S, Hanisch JU, Aidelsburger P, et al. Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 2007;6:22-29
16. He Y, Jiang B, Wang J, et al.; Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006;47:1588-1594
17. Choi KM, Kim SM, Kim YE, et al. International Diabetes Federation. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism 2007;56:552-558
18. Tong PC, Kong AP, So WY, et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007;30:1206-1211
19. Liberopoulos EN, Elisaf MS. Diagnosis of the metabolic syndrome: which definition should we use? Hellenic J Cardiol 2005;46:258
20. Athyros VG, Karagiannis A, Hatzitolios AI, et al.; SAGE-METS collaborative group. Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study. Curr Med Res Opin 2009;25: 971-980
21. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005;28:385-390
22. Milionis HJ, Liberopoulos E, Goudevenos J, et al. Risk factors for first-ever ischemic non-embolic stroke in elderly individuals. Int J Cardiol 2005; 99:269-275
23. Liberopoulos EN, Tsouli S, Mikhailidis DP, et al. Preventing type 2 diabetes in high risk patients: An overview of lifestyle and pharmacological measures. Curr Drug Targets 2006;7:211-228
24. Athyros VG, Mikhailidis DP, Papageorgiou AA, et al. Targeting vascular risk in patients with metabolic syndrome but without diabetes. Metabolism 2005; 54:1065-1074
25. Liberopoulos EN, Mikhailidis DP, Elisaf MS. Diagnosis and management of the metabolic syndrome in obesity. Obes Rev 2005;6:283-296
26. Filippatos TD, Kiortsis DN, Liberopoulos EN, et al. Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study. Curr Med Res Opin 2005;21:1997-2006
27. Gü ndogan K, Bayram F, Capak M, et al. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metab Syndr Relat Disord 2009; 7:427-434
28. Esposito K, Maiorino MI, Ciotola M, et al. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Ann Intern Med 2009; 151:306-314
29. Romaguera D, Norat T, Mouw T, et al. Adherence to the Mediterranean diet is associated with lower abdominal adiposity in European men and women. J Nutr 2009;139:1728-1737
30. Sarrafzadegan N, Kelishadi R, Dana Siadat Z, et al. Obesity and cardiometabolic risk factors in a representative population of Iranian adolescents and adults in comparison to a Western population: the Isfahan Healthy Heart Programme. Public Health Nutr 2009 [Epub ahead of print]